asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Anyone who meets the diagnostic criteria of Western medicine and the criteria of Chinese medicine evidence; (2) Aged between 3 and 12 years, regardless of gender; (3) Those who have an acute onset and whose condition is mild or moderate according to the criteria for assessment; (4) No treatment has been given in the last 3 days.
Exclusion criteria
Exclusion criteria: (1) Stable or in remission from asthma; (2) Severe asthma, persistent asthma, critically ill patients, and those with co-infections of the lungs; (3) Patients with other diseases that cause shortness of breath or dyspnea and affect the assessment of efficacy; (4) Patients with primary diseases of the cardiovascular, cerebrovascular, hepatic, renal and haematopoietic systems; (5) Patients who are allergic to the components of the drug used in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time for clinical symptoms to disappear;Chinese Medicine Evidence Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Lung function indicators;Blood Eosinophil Count;Exhaled breath condensate detection;Peak flow rate detection; | — |
Countries
China
Contacts
Affiliated Hospital of Nanjing University of Chinese Medicine